Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- Today, Visa, a world leader in digital payments, announced its support for Chinese Visa cardholders to pay with Apple Pay. Together with Apple, Visa will enable Chinese cardholders to add Visa cards[1] from...
HTX Hot Listings Weekly Recap (Jan 5-11): Binance Life and ZKP Lead the Rally as First-Mover Advantage Continues to Shine
PANAMA CITY, Jan. 15, 2026 /PRNewswire/ -- The cryptocurrency market remains range-bound amidst the interplay of macro uncertainty and gradually recovering sentiment at the start of 2026. Against a backdrop of relatively modest market-wide gains,...
"The Insiders Forum" by Travellive Media Group: Trends Shaping Tourism Strategy
HANOI, Vietnam, Jan. 15, 2026 /PRNewswire/ -- As Vietnam's tourism sector enters a post-pandemic restructuring phase, trends with the potential to generate long-term value are increasingly taking centre stage in the industry's development...
Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease
SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its...
CLO Secures Final Victory in Software Copyright Infringement Case Against Style3D; Court Recognizes Large-Scale Commercial Piracy
SHANGHAI, Jan. 15, 2026 /PRNewswire/ -- CLO Virtual Fashion ("CLO"), a leading provider of 3D fashion technology and end-to-end digital solutions, today announced that it has obtained a final and binding judgment from the Zhejiang Provincial High...
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects in 2025 set a new record, with approximately 50% originating from U.S. clients Complex modalities...
Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral 'XAFTY' Following 2026 Biotech Showcase Consensus
- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks" strategy: Targeting Dengue in Vietnam and Respiratory Viruses (Flu, COVID, RSV) in the U.S. with the...
"Galaxy Macau Presents: The Jimmy O. Yang Chinese New Year Show" Proudly Supported by Manulife
HONG KONG and MACAU, Jan. 15, 2026 /PRNewswire/ -- Manulife Hong Kong and Macau ("Manulife") is proud to support "Galaxy Macau Presents: The Jimmy O. Yang Chinese New Year Show," underscoring its commitment to mental well-being as an essential...